Intracranial Hemorrhage, Hypertensive Clinical Trial
Official title:
A Pilot Study of Safety and Efficacy of Intravenous Immunoglobulin Therapy in Patients With Acute Intracranial Hemorrhage
This pilot study aims to investigate whether intravenous immunoglobulin is safe and effective in alleviating perihematomal edema and neurologic deficits in patients with intracranial hemorrhage.
The trial consists of two groups: IVIg group and control group. Thirty patients will be recruited into IVIg group. Thirty Patients who are matched for age, gender, National Institutes of Health Stroke Scale scores, hematomal volumes, and locations of hematomas, will be selected into control group. Patients in control group just receive standard management, while those in IVIg group will receive standard management plus intravenous immunoglobulin therapy. The outcome assessor is blinded to the group assignments. ;
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03153150 -
Start or STop Anticoagulants Randomised Trial (SoSTART)
|
Phase 3 | |
| Not yet recruiting |
NCT06429657 -
Ketamine for Sedation in Severe Traumatic Brain Injury
|
Phase 4 | |
| Completed |
NCT02811614 -
Minimally-invasive Surgery Versus Craniotomy in Patients With Supratentorial Hypertensive Intracerebral Hemorrhage
|
N/A | |
| Recruiting |
NCT03995940 -
Neurological Outcomes of Primary Intracerebral Haemorrhage
|
||
| Completed |
NCT01689402 -
MRI for the Early Evaluation of Acute Intracerebral Hemorrhage
|
||
| Recruiting |
NCT05778110 -
Multiomic Analysis of Traumatic Brain Injury and Hypertension Intracranial Hemorrhage Lesion Tissue
|